The present invention relates to compounds of formula (I)
##STR1##
wherein A1, A2, A3, A4, A5,
A6, U, V, m, n and o are as defined in the specification, and pharmaceutically
acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis
of diseases which are associated with the 2,3-oxidosqualene-lanosterol cyclase
biosynthetic pathway such as hypercholesterolemia and hyperlipemia.
